EFFICACY AND SAFETY OF GASTRO-RESISTANT PHOSPHATIDYLCHOLINE (LT-02) FOR INDUCTION OF REMISSION IN PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS REFRACTORY TO MESALAZINE: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (PCG-2)

(1) Agaplesion Markus Krankenhaus,Frankfurt,Germany

(2) Medizinische Universität Wien,Wien,Austria

(3) Endoskopia Sp.,Sopot,Poland

(4) O.O. Bogomolets National Medical University,Kiew,Ukraine

(5) Praxis für Gastroenterologie,Berlin,Germany

(6) Kliniken Essen-Mitte Integrative Gastroenterologie,Essen,Germany

(7) Universitaetsklinikum Schleswig-Holstein, Campus Luebeck,Luebeck,Germany

(8) Asklepios West-Klinikum,Hamburg,Germany

(9) Medizinische Universität Wien,Vienna,Austria

(10) Medizinische Uniklinik Freiburg,Freiburg,Germany

(11) Interdisciplinary Crohn Colitis Centre Rhein-Main,Frankfurt,Germany

(12) Internistische Gemeinschaftspraxis,Ludwigshafen,Germany

(13) Dr. Falk Pharma GmbH,Freiburg,Germany

(14) Universitätsklinik Heidelberg,Heidelberg,Germany



This item was part of UEG Week 2018

This item can be cited as: United European Gastroenterology Journal 2018; 6 (Supplement 1)